Bortezomib
NDC 31722-303, Bortezomib, injection, powder, lyophilized, for solution, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-303
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-303 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB3.5 mg/1
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-303-31 | 31722030331 | 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-303-31) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/04aafa6a-a50d-4a47-a831-be8e8bb992ac
Use it
Look up 31722-303 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-303 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-303. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.